Corporate-government restricts free market in drugs |
Llewellyn H. Rockwell, Jr.
Lew Rockwell
The American pharmaceutical system is a highly controlled apparatus for restricting access to much-needed drugs and violating the rights of those who want to purchase them. This has long been true.
Vast amounts of drugs that people should be permitted to purchase of their own free will are withheld from the market (of course, many others are outlawed). Instead, people who know what they need are forced first to fork over their money to a physician – who then gets overpaid by insurance – then part of the buck is passed to the over-trained checkout clerks at the pharmacy. We are all treated like babies in order to sustain and fund an industry filled with bamboozlers in white coats.
The Internet in its early days (perhaps 1998 to 2008) represented a wonderful alternative to this apparatus. Suppliers all over the world popped up to give us what we wanted, bypassing the whole cage of government regulations and private monopolists who rule them like prison wardens. You know what you need, so just click and buy it!
So the pharmaceutical industry solicited the help of government. Together, they worked to crack down on “counterfeit” medicines – meaning the real thing that bypasses patent restrictions and supplier monopolies. In their view, people must not be allowed to get prescription medications without doctor approval – else an entire fake industry could collapse. So they bandied together and instituted a medieval guild system for the digital age.
Over the years, Google has accepted some advertising from some of these so-called rogue elements. In a free market, they would be perfectly legitimate advertisers. Google makes no guarantee of the exact nature of the goods and services of all those who choose to advertise on its network. It has some degree of interest in quality control, of course, but if the customers are buying and happy, what could be the problem?
linkwithin_text=’Related Articles:’
Be the first to comment on "The Google Pharm Case"